[Assessment of effects of angiotensin converting enzyme inhibitor perindopril on function of endothelium of arterial vessels in patients with ischemic heart disease and hypertension].
L L
LL
Kirichenko
M A
MA
Iarygina
A P
AP
Korolev
V P
VP
Masenko
O S
OS
Tseka
T V
TV
Rusak
E A
EA
Panchenkova
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D001783:Blood Flow Velocity; D001916:Brachial Artery / Q000187:drug effects* / Q000502:physiology; D002851:Chromatography, High Pressure Liquid; D003627:Data Interpretation, Statistical; D016232:Endothelins / Q000097:blood; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000502:physiology; D011464:Epoprostenol / Q000097:blood; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000503:physiopathology; D009569:Nitric Oxide / Q000097:blood; D020913:Perindopril / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D013931:Thromboxanes / Q000097:blood; D013997:Time Factors; D014664:Vasodilation
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D016232:Endothelins; D013931:Thromboxanes; D009569:Nitric Oxide; D011464:Epoprostenol; D020913:Perindopril